| Literature DB >> 35620619 |
Diawo Diallo1, Babacar Diouf1, Alioune Gaye1, El Hadji NDiaye1, Ndeye Marie Sene1, Ibrahima Dia1, Mawlouth Diallo1.
Abstract
Dengue fever is a mosquito-borne-disease of growing public health importance in Africa. The continuous increase of number and frequency of outbreaks of dengue fever, especially in urban area in Africa underline the need to review the current data available on vectors involved in dengue virus transmission in Africa. Here, we summarized the available data on vectors involved in the transmission of dengue virus in the sylvatic and urban environments, vertical transmission, vector competence studies, and vector control strategies used in Africa. The virus was isolated mainly from Aedes furcifer, Ae. luteocephalus, and Ae. taylori in the sylvatic environment and from Ae. aegypti and Ae. albopictus in the urban areas. Prospective and urgently needed studies on vectors biology, behavior, and alternative control strategies are suggested.Entities:
Keywords: Africa; Dengue; Mosquito vectors; Sylvatic; Urban
Year: 2022 PMID: 35620619 PMCID: PMC9126922 DOI: 10.1016/j.heliyon.2022.e09459
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Figure 1Map showing African countries where dengue circulation has been detected in local populations or travelers.
Mosquito species found naturally infected with dengue virus in Africa.
| Environment | Countries | Species | Years | Serotypes | References |
|---|---|---|---|---|---|
| Urban | Senegal | 2009 | 3 | [ | |
| Burkina Faso | 1982, 1986 | 2 | [ | ||
| Nigeria | 1969 | 2 | [ | ||
| Côte d’Ivoire | 2017 | 3 | [ | ||
| Tanzania | 2014 | 2 | [ | ||
| Kenya | 2014 | 2 | [ | ||
| Sudan | 2016–17 | ?? | [ | ||
| Cabo Verde | 2009, 2014-15 | 2, 3, 4 | [ | ||
| Seychelles | 1976–77 | 2 | [ | ||
| Gabon | 2007, 2010 | 2 | [ | ||
| Rural/Sylvatic | Senegal | 1974, 1981–82, 1989, 1999–2000 | 2 | [ | |
| Burkina Faso | 1980, 1983, 1986 | 2 | [ | ||
| Côte d’Ivoire | 1980, 1985-87 | 2 | [ | ||
| Nigeria | 1969, 1977 | 1, 2, 3 | [ | ||
| Guinea Conakry | 1981 | 2 | [ |
Figure 2Map showing African countries where dengue virus was detected from mosquitoes in the urban (A) and sylvatic/Rural cycle (B), and vector competence studies (C) were done.
Mosquito species originated from Africa competent for dengue virus.
| Species | Mosquito tested | Titer of the blood meals | Virus serotype (strains; Origin) | Origin | Inf (%) | Diss (%) | Trans (%) | DPE (days) | References | |
|---|---|---|---|---|---|---|---|---|---|---|
| Country | localities | |||||||||
| Senegal | Kedougou, Koung Koung, | 106.5 and 1.6 × 107 TCID50/mL | DENV-2 (ArD 140875; Kedougou) | Sylvatic | 0–26 | 0–75 | 14 | [ | ||
| 106.5 TCID50/mL | DENV-2 (ArA 6894; Bobo-Dioulasso) | Epidemic | 0–1.85 | 50–100 | 14 | |||||
| Koung Koung, Kedougou | 6.2–8.8 log10 TCID50/mL | DENV-2 (NGC; New Guinea and 1349; Burkina Faso) | Epidemic | 0–25 | 67–100 | 14 | [ | |||
| 6.2–8.8 log10 TCID50/mL | DENV-2 (PM33974; Guinea and DakAr2022; Burkina Faso) | Sylvatic | 0–3 | 0–100 | 14 | |||||
| Dakar, St-Louis, Kedougou | 4.9 × 106–4.7 × 107 PFU/mL | DENV-1 (SH 29177; Bandia) | Epidemic | 71.4–92.5 | 50–93.8 | 2.9–5.9 | 7,15 | [ | ||
| 3.5 × 106–2.4 × 107 PFU/mL | DENV-3 (S-162 TvP-3622; Somalia) | Epidemic | 62.5–100 | 50–88.2 | 3.3–7.5 | |||||
| 1.2 × 106–2.6 × 107 PFU/mL | DENV-4 (SH 38549; Dakar) | Epidemic | 71.4–93.8 | 56.7–93.8 | 2.9–20 | |||||
| Saint-Louis, Digale, Dakar, Ngoye, Tambacounda, | 107.5–8.5 pfu/mL | DENV-2 (JAM1409; Jamaica) | Epidemic | up to 90 | 14 | [ | ||||
| Kedougou, Fatick, Bignona, Richard-Toll, | 6.02 log10 PFU/mL | DENV-2 (75505; Kedougou) | Sylvatic | 50–91 | 29–93 | 14 | [ | |||
| Dakar, Kedougou | 5.104.2 and 5.104.4 MID50 ⁄ mL | DENV3 (H87; Hawaii) | Epidemic | 2.4–15.2 | 0–8.3 | xx | 7, 15,20 | [ | ||
| Dakar, Kedougou | 5.103.3 and 5.104.3 MID50 ⁄ mL | DENV1_IbH28328; Ibadan) | up to 50 | up to 50 | xx | |||||
| South Africa | Palm Beach, Durban, | 6.1–8.4 Log10 MID50/mL | DENV-1 (Cassim, Durban) | Epidemic | NA | 6–68 | 50–100 | 13–20 | [ | |
| 7.0–7.9 Log10 MID50/mL | DENV-2 (BC 5007, Taipei) | Epidemic | NA | 11–64 | 33–100 | 14–20 | ||||
| Cape Verde | Santiago (seven counties) | 2 × 105–5 × 104 FFU/mL | DENV-1 (42735; BR PE) | Epidemic | 0–27 | 0–100 | 0 | 7,14,21 | [ | |
| 1.4 × 105–2 × 105 FFU/mL | DENV-2 (3808; BR-PE) | Epidemic | 50–80 | 20–93.3 | 5.0–65.0 | 7, 14,21 | ||||
| 1.0 × 106–2 × 106 FFU/mL | DENV-3 (85469; BR-PE) | Epidemic | 10–80 | 50–87.5 | 0.0–75.0 | 7,14,21 | ||||
| 1.0 × 106–2 × 106 FFU/mL | DENV-4 (1385; Brazil) | Epidemic | 0–9 | 0 | 0 | 7,14,21 | ||||
| 107 FFU/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 41.6 | 8.3 | 14 | [ | ||||
| 107 FFU/mL | DENV-3 (Praia; Cabo Verde) | Epidemic | 27.3–80 | 0–20 | 7,10,14 | |||||
| Madagascar | Mahaleja, Joffreville | 108.2 MID50/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 25.0–40.0 | xx | x | 14 | [ | |
| Cameroon | 19 localities including Douala, | 108.1 MID50 ⁄ mL | DENV-2 (D2S32; Bangkok) | Epidemic | 17.2–59.7 | [ | ||||
| Yaoundé, Douala, Tibati and Bénoué National Park | 107 FFU/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 70.8–100 | 58.8–100 | 0–50 | 14,21 | [ | ||
| Kenya | Kilifi, Nairobi | 105.08 PFU/ml | DENV-2 (008/01/2012; Mandera) | Epidemic | 6.8–21 | 7.02–42.9 | 7,14,21 | [ | ||
| Gabon | Franceville | 108.2 MID50/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 52.0, 69.6 | 14 | [ | |||
| Nigeria | Lagos | 0 .001 PFU/mL | DENV-2 (NGC; New Guinea) | Epidemic | 37–56 | [ | ||||
| Burkina Faso | Kari | 0 .001 PFU/mL | DENV-2 (NGC; New Guinea) | Epidemic | 0 | [ | ||||
| Ghana | Hohoe, Accra, Larabanga, Jirapa | 1×106 FFU/mL | DENV-1 (/NIID100/2014; Saitama) | 15.4–75.9 | 0–90.9 | 0 | 7,14 | [ | ||
| 1×106 FFU/mL | DENV-2 (F299/2017; Ghana) | 0–30.2 | 0–12.5 | |||||||
| Republic of Congo | Brazzaville | 107 ffu/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 77.3–95.8 | 88.2–95.6 | 36.4 | 14,21 | [ | |
| Madagascar, | Anamakia, Antsiranana, Joffreville | 108.2 MID50/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 33.3–93.0 | xx | xx | 14 | [ | |
| Gabon | Libreville | 108 MID50 ⁄ mL | DENV-2 (D2S32; Bangkok) | Epidemic | 13, 21.4 | 14 | [ | |||
| Cameroon | 12 localities including Yaoundé and Douala | 108.1 MID50/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 13.3–47.5 | 14 | [ | |||
| Yaoundé, Douala, Tibati | 14,21 | [ | ||||||||
| Republic of Congo | Brazzaville | 107 ffu/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 14,21 | [ | ||||
| La Reunion Island | 10 localities including La Marine, | 108.2 MID50/mL | DENV-2 (D2S32; Bangkok) | Epidemic | 18–52 | 14 | [ | |||
| Senegal | Kedougou | 6.5–9.2 TCID50/mL | DENV-2 (NGC; New Guinea and 1349; Burkina Faso) | Epidemic | 58–94 | 22–75 | 14 | [ | ||
| Kedougou | 7.0–8.0 TCID50/mL | DENV-2 (PM33974; Guinea and DakAr2022; Burkina Faso) | Sylvatic | 26–97 | 0–48 | |||||
| Kedougou | 1.6 × 106 | DENV-4 (Haiti73; Haiti) | Epidemic | 88.5 | 84.6 | 0 | [ | |||
| 3.1 × 106 | DENV-3 (Carec 01–11828; Barbados) | Epidemic | 86.6 | 77.8 | 0 | |||||
| South Africa | Mica | 6.8–7.1 Log10 MID50/mL | DENV-1 (Cassim; Durban) | 0–3 | 0 | 15,17 | [ | |||
| Mica, Ndumu | 8.2–8.4 Log10 MID50/mL | DENV-2 (BC 5007; Taipei) | 9, 17 | 50 | 15–18 | |||||
| Senegal | Kedougou | 5.5–8.2 TCID50/mL | DENV-2 (NGC; New Guinea and 1349; Burkina Faso) | Epidemic | 0–89 | 50 | [ | |||
| 5.5–9.2 TCID50/mL | DENV-2 (PM33974; Guinea and DakAr2022; Burkina Faso) | Sylvatic | 58–79 | 13–27 | ||||||
| 1.4 × 106 PFU/mL | DENV-4 (SH 38549; Dakar) | Epidemic | 77.3 | 72.7 | 4.5 | 7,15 | [ | |||
| Kedougou | 4.9 × 106 PFU/mL | DENV-1 (SH 29177; Bandia) | Epidemic | 68 | 64 | 0 | [ | |||
| 3.5 × 106 PFU/mL | DENV-3 (S-162 TvP-3622; Somalia) | Epidemic | 76.7 | 76.7 | 6.7 | 7,15 | ||||
| 2.6 × 107 PFU/mL | DENV-4 (SH 38549; Dakar) | Epidemic | 83.9 | 77.4 | 0 | |||||
| South Africa | Palm Beach | 7.1 | DENV-1 (Cassim; Durban) | Epidemic | 33 | 0 | 12,14 | [ | ||
| Palm Beach, Armadale | 7.1–7.8 | DENV-2 (BC 5007; Taipei) | Epidemic | 54, 60 | 29 | 14–16 | ||||
| Senegal | Kedougou | 5.8 TCID50/mL | DENV-2 (NGC; New Guinea) | Epidemic | 0 | 14 | [ | |||
| 6.5–8.8 TCID50/mL | DENV-2 (PM33974; Guinea and DakAr2022; Burkina Faso) | Sylvatic | 6 and 19 | 60, 100 | ||||||
TCID50/mL: 50% tissue culture infectious doses; MID50/mL: 50% of mosquito infectious dose for Ae. aegypti; PFU/ml: Plaque formed unit; ffu/ml: Foci-Formed unit; Inf: infection rate; Diss: Dissemination rate; Trans: transmission rate; DPE: days post exposure when mosquitoes were tested.